Thalidomide-NH-C5-NH2 hydrochloride is primarily utilized in the field of medicinal chemistry for its potential therapeutic applications. It is being studied for its role in modulating immune responses and inhibiting angiogenesis, which makes it a candidate for treating certain cancers and autoimmune diseases. Researchers are exploring its efficacy in targeting specific pathways involved in tumor growth and inflammation. Additionally, its structural modifications aim to enhance bioavailability and reduce adverse effects, making it a promising compound for further drug development.